Researcher
Elisabeth Hens
- Keywords:Medicine
Affiliations
- Neuroprotection & Neuromodulation (Research group)
Member
From12 May 2023 → Today - Neurology (Department)
Member
From1 Aug 2019 → 31 Jul 2023
Publications
1 - 5 of 5
- Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease(2021)
Authors: Stefanie Smolders, Stéphanie Philtjens, David Crosiers, Anne Sieben, Elisabeth Hens, Bavo Heeman, Sara Van Mossevelde, Philippe Pals, Bob Asselbergh, Roberto Dos Santos Dias, et al.
- Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients(2021)
Authors: Liene Bossaerts, Elisabeth Hens, Bernard Hanseeuw, Rik Vandenberghe, Patrick Cras, Peter P De Deyn, Sebastiaan Engelborghs, Christine Van Broeckhoven
Pages: 307.e1-307.e7 - Investigation of the role of matrix metalloproteinases in the genetic etiology of Alzheimer's disease(2021)
Authors: Julie Hoogmartens, Elisabeth Hens, Sebastiaan Engelborghs, Peter Paul De Deyn, Julie Van Der Zee, Christine Van Broeckhoven, Rita Cacace
Pages: 105.e1-105.e6 - Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease(2021)
Authors: Julie Hoogmartens, Elisabeth Hens, Sebastiaan Engelborghs, Rik Vandenberghe, Peter De Deyn, Rita Cacace, Christine Van Broeckhoven
Pages: 100.e17-100.e23 - Amyloid-beta(1-43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations(2020)
Authors: Federica Perrone, Maria Bjerke, Elisabeth Hens, Anne Sieben, Maarten Timmers, Arne De Roeck, Rik Vandenberghe, Kristel Sleegers, Jean-Jacques Martin, Peter De Deyn, et al.